Try our Advanced Search for more refined results

November 02, 2015

AstraZeneca LP et al v. Mylan Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. November 03, 2015

    AstraZeneca Hits Mylan With Patent Suit Over Blood Thinner

    Mylan has infringed five of AstraZeneca's patents by filing an abbreviated new drug application with the U.S. Food and Drug Administration to make a generic version of AstraZeneca's blood thinner Brilinta, according to a suit filed Monday in West Virginia federal court.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login